Yuyu Pharma, Inc. (000227.KS)

Yuyu Pharma, Inc. (000227.KS) — VMCI valuation read

Across 120 indicators, Yuyu Pharma, Inc. (000227.KS) lands at VMCI 62/100. The broad-market sample median is 50, so the 12-point above-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on 000227.KS in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, 000227.KS trades at 17.0x earnings, 6% below the sector median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 9.0% trails the sector median (10.0%) by 1.0pp. On Risk, net debt to EBITDA of 1.8x is the rate-sensitivity line to watch for 000227.KS on the trailing balance sheet.

000227.KS rose 2.5% over the trailing 7 days, with a -19.7% read on a 30-day basis.